Dr. Byung-in Lee is the CEO of Diagnomics. Dr. Lee joined Diagnomics in 2016, having had extensive product development and molecular diagnostic experience, serving most recently as VP-Operations at Maverix Biomics for their NGS data analysis platform development and for molecular diagnostics. Previously, he held the position of a Senior Director at Pathway Genomics and AltheaDx, where he led biomarker discovery and molecular diagnostic implementation for companion diagnostics to support clinical trials. Additionally, Dr. Lee held managerial roles at Life Technologies Inc. (now Thermo-Fisher) for Research & Development. He earned his doctorate from University of Illinois and was a Postdoctoral Fellow at the Lawrence Livermore National Laboratory.